On Holding AG (ONON) concluded trading on Wednesday at a closing price of $27.87, with 4.14 million shares of worth about $115.24 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -21.93% during that period and on Wednesday February 7 the price remained unchanged. Currently the company’s common shares owned by public are about 281.98M shares, out of which, 185.84M shares are available for trading.
Stock saw a price change of 4.93% in past 5 days and over the past one month there was a price change of -1.17%. Year-to-date (YTD), ONON shares are showing a performance of 3.34% which increased to 23.92% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $19.90 but also hit the highest price of $37.08 during that period. The average intraday trading volume for On Holding AG shares is 5.15 million. The stock is currently trading 1.28% above its 20-day simple moving average (SMA20), while that difference is down -1.12% for SMA50 and it goes to -5.22% lower than SMA200.
On Holding AG (NYSE: ONON) currently have 281.98M outstanding shares and institutions hold larger chunk of about 39.53% of that.
The stock has a current market capitalization of $8.87B and its 3Y-monthly beta is at 2.07. PE ratio of stock for trailing 12 months is 99.96, while it has posted earnings per share of $0.28 in the same period. It has Quick Ratio of 2.21 while making debt-to-equity ratio of 0.23. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ONON, volatility over the week remained 3.66% while standing at 3.96% over the month.
Analysts are in expectations that On Holding AG (ONON) stock would likely to be making an EPS of $Tenon Medical, Inc. in the current quarter, while forecast for next quarter EPS is $1.21 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $ProShares Online Retail ETF which is $ONOF at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $Global X Adaptive U.S. Risk Man in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 73.86% while it is estimated to increase by 42.92% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Truist on November 17, 2023 offering a Hold rating for the stock and assigned a target price of $29 to it.
